These findings open several promising research avenues that have not been thoroughly explored. what are the effects of sleep or REM sleep deprivation on these RAS mechanisms? Are these mechanisms involved in memory processing during waking and/or during REM sleep? Does gamma band processing differ during waking versus REM sleep after sleep or REM sleep deprivation?
1 3 (Corsi-Cabrera et al. 1987) , that could be critical not only for memory consolidation, but also for the consolidation of emotional events (walker 2009) and emotional reactivity (Gujar et al. 2011) .
Gamma oscillations emerge from the dynamic interaction between intrinsic membrane and synaptic properties of thalamocortical networks (Steriade and Llinás 1988) . The neuronal networks behind such activity include the presence of inhibitory cortical interneurons with intrinsic membrane potential oscillatory activity in the gamma range (Steriade and Llinás 1988; Llinas et al. 1991; Steriade 1999) , many of which are electrically coupled (Gibson et al. 1999) , as well as of fast rhythmic bursting pyramidal neurons (Cunningham et al. 2004) . At the thalamic level, thalamocortical excitatory neurons have intrinsic properties needed to generate subthreshold gamma band membrane potential oscillations (Pedroarena and Llinás 1997) .
while cortical interneurons can generate membrane potential gamma oscillations through the activation of voltage-dependent, persistent sodium channels (Llinas et al. 1991) , and metabotropic glutamate receptors (whittington et al. 1995) , in thalamocortical neurons, the mechanism responsible for gamma band activity involves high-threshold P/Q-type voltage-gated calcium channels located in the dendrites (Pedroarena and Llinás 1997; whittington et al. 1995) . Moreover, the same intrinsic properties mediating gamma band oscillations are present in the thalamus of several vertebrate species, indicating considerable evolutionary conservation (Llinás and Steriade 2006) . However, very little is known about the effects of sleep disturbances, including sleep deprivation or REM sleep deprivation on these intrinsic mechanisms in the cortex. Even less is know about such effects on subcortical gamma band mechanisms.
The reticular activating system (RAS) is known to control the manifestation of cortical gamma band activity during waking and during REM sleep. we recently described the presence of gamma band activity as part of the intrinsic properties of neurons in various nuclei of the RAS. we found that almost all cells in the mesopontine pedunculopontine nucleus (PPN) and its ascending target, the intralaminar thalamic parafascicular nucleus (Pf), as well as the descending target, the SubCoeruleus nucleus dorsalis (SubCD), were capped to fire at gamma frequencies (40-60 Hz), but no higher (Simon et al. 2010 Kezunovic et al. 2012) . we found that this activity was subserved by voltage-dependent, high-threshold N-and P/Q-type calcium channels in the PPN and Pf (Kezunovic et al. , 2012 , and by sodiumdependent subthreshold oscillations in the SubCD . we localized N-and P/Q-type calcium channelmediated gamma oscillations to the dendrites of PPN and Pf cells (Hyde et al. 2013a, b) . Figure 1a provides a schematic of the mechanism described for the PPN, in which P/Q-type calcium channels mediate the depolarizing phase of each oscillation, while rectifier-like potassium channels mediate the repolarizing phase, all at gamma frequencies ). This figure also provides an example of calcium imaging of the dendrites (Fig. 1b) , showing calcium transients in relation to electrophysiologically recorded oscillations in a PPN neuron (Fig. 1c) .
The SubCD, the descending target of the PPN, is different. The SubCD is critical to the generation of REM sleep and its characteristic atonia and ponto-geniculo-occipital (PGO) waves (P-waves in the rat) (Aserinsky and Kleitman 1953; Datta et al. 1998 ). The SubCD is most active during REM sleep (Boissard et al. 2002; Datta et al. 2009) , and injection of the nonspecific cholinergic agonist carbachol induced a REM sleep-like state with muscle atonia and PGO waves (Baghdoyan et al. 1987; Boissard et al. 2002; Mitler and Dement 1974) . Lesion of this region produced REM sleep without atonia or PGO waves (Sanford et al. 1994; Mavanji et al. 2004) . The SubCD receives cholinergic input from the PPN and projects to many areas, including the lateral geniculate nucleus and hippocampus (Datta et al. 1998 (Datta et al. , 1999 . we found that SubCD neurons were also capped with fire at gamma band frequencies, but the mechanism responsible for firing at these frequencies was identified as sodium-dependent subthreshold oscillations Urbano et al. 2013) , like those mediating gamma oscillations in some cortical interneurons (Llinas et al. 1991) . Therefore, we speculate that the generation of gamma band activity during REM sleep may primarily include the PPN-SubCD pathway, while during waking, it may primarily use the PPN-Pf/intralaminar thalamus pathway. There is another difference between the gamma band activity during waking and that during REM sleep in that the latter is generated during a relative decrease in frontal lobe blood flow (Maquet et al. 1966 ). This suggests that there is a lack of critical judgment during REM sleep and dreaming . This is perhaps why, during the REM sleep state, in which we are relatively (to waking) disconnected from the external world, the brain manufactures dreams that are not bound by critical judgment, and can be considered cognitively "aberrant." we explore below the issue of whether gamma band activity during waking is different from that during REM sleep.
These results suggest that a similar mechanism to that in the cortex for achieving temporal coherence at high frequencies is present in the PPN, and in its subcortical targets such as the Pf and SubCD nuclei. That is, the PPN generates and relays gamma band activity to its ascending target, the Pf, as well as to its descending target, the SubCD, and they each have the appropriate intrinsic membrane properties to in turn relay gamma frequency activity to their targets. we suggested that gamma band activity and electrical coupling in the PPN helps stabilize coherence related to arousal, providing a stable activation state during waking and paradoxical sleep (Kezunovic et al. 2010 Simon et al. 2010) . we further proposed that sensory input induces gamma band activity in the RAS that participates in the process of preconscious awareness Urbano et al. 2013) , that is, in the essential mechanism that allows the uninterrupted flow of afferent sensory information, the background tone, necessary for the "stream of consciousness," as coined by william James. The RAS seems the ideal site for preconscious awareness since it is phylogenetically conserved, and modulates sleep/wake cycles, the startle response, and fight-versus-flight responses that include changes in muscle tone and locomotion.
Gamma maintenance
It has been suggested that consciousness is associated with continuous gamma band activity, as opposed to an interrupted pattern of activity (vanderwolf 2000a, b) . The original description of the RAS specifically suggested that it participates in tonic or continuous arousal, and lesions of this region were found to eliminate tonic arousal (Moruzzi and Magoun 1949; watson et al. 1974) . This raises the question of how a circuit can maintain such rapid, recurrent activation for long periods. Expecting a circuit of 8-10 synapses to reliably relay 30-60 Hz cycling without failing is unrealistic. without the intrinsic membrane properties afforded by rapidly opening channels such as those described for PPN, Pf, and subthreshold oscillations in SubCD, as well as the presence of electrically coupled neurons that help firing across different membrane potentials , gamma band activity could not be maintained. The combination of (a) channels capable of mediating fast membrane oscillations and (b) circuitry that involves activating these channels is probably required for the maintenance of gamma band activity (Llinas 1988 ; Fig. 1 Model of high-threshold, voltage-dependent P/Q-type calcium channel oscillations and visualization of calcium transients in the dendrite of a PPN neuron. a Application of a ramp stimulus in the presence of synaptic blockers and TTX slowly depolarizes the membrane, avoiding the activation of potassium channels. Once the voltage-dependent high threshold of calcium channels is reached, ~ −30 mv, membrane oscillations are observed. Addition of the specific P/Q-type calcium channel blocker ω-agatoxin-IvA will eliminate the oscillations, demonstrating that the depolarizing phase is due to P/Q-type calcium channels (Ca v 2.1). Addition of the delayed rectifier-like potassium channel blocker dendrotoxin also blocks the oscillations, demonstrating that the repolarizing phase is due to these potassium channels (K v 1.1, K v 1.2, K v 1.6) (Kezunovic et al. 2012) . b Electrophysiological recording of a PPN cell during ramp-induced membrane oscillations (black record), while region of interest calcium transients were imaged from the cell body (blue record) and one of the dendrites (green record). The peaks of the calcium oscillations coincided with the peaks in the electrical recording, and different dendrites (not shown) manifested calcium transients coinciding with different peaks of the soma recording (Hyde et al. 2013b) . c Locations of the regions of interest shown in (b) in a photomicrograph of a PPN cell injected with fluorescent dye, with the microelectrode evident on the right 1 3 Llinas et al. 1991 Llinas et al. , 2002 Llinas et al. , 2007 Kezunovic et al. 2011) . RAS structures in which every cell in every nucleus exhibit gamma band activity and, in which a subgroup of cells manifest electrical coupling, then becomes a gamma-making machine. we speculate that it is the activation of the RAS during waking and REM sleep that induces coherent activity (through electrically coupled cells) and high-frequency oscillations (through P/Q-type calcium channel and subthreshold oscillations). This leads to the maintenance of the background of gamma activity necessary to support a state capable of reliably assessing the world around us on a continuous basis. That is, these mechanisms may underlie preconscious awareness. However, we do not know how such a process is altered during REM sleep compared to waking, or its participation in memory consolidation and emotional responsiveness.
Three questions
These suggestions raise additional complex questions, among others, which we have been pursuing to the next level of analysis, the intracellular mechanisms involved. what intracellular mechanism(s) mediate the maintenance of gamma band activity? Are the mechanisms behind gamma band activity different during waking than during REM sleep? what intracellular mechanisms are involved in pathological states such as schizophrenia?
A mechanism for gamma maintenance
The PPN receives cholinergic input from the contralateral PPN and the laterodorsal tegmental nuclei (Semba and Fibiger 1992) . PPN cholinergic neurons are hyperpolarized by the activation of postsynaptic muscarinic M2 cholinergic receptors (Luebke et al. 1993; Leonard and Llinas 1994) . Studies from our laboratory showed that 73 % of PPN output neurons were inhibited through M2 receptors, 13 % were excited through M1 and nicotinic receptors, and 7 % showed biphasic responses (Ye et al. 2010 ). The most abundant receptor type in the PPN is the M2 muscarinic receptor, which is G i -protein coupled. Recently, we found that acute/short lasting application of the nonspecific cholinergic agonist carbachol (CAR) reversibly blocked PPN rampinduced oscillations ( Fig. 2a) ). This study showed that acute CAR application blocked P/Q-type calcium channel-mediated oscillations in the PPN through M2 muscarinic receptors, suggesting that phasic cholinergic input to PPN cells leads to an inhibition of high-frequency oscillations . we conclude that temporary membrane hyperpolarization caused by M2 receptor activation explains the acute inhibitory effect of CAR on the oscillatory activity in PPN neurons.
However, when CAR was applied for a prolonged period of time, CAR increased the frequency (but not the amplitude) of the oscillations (Fig. 2b) . A specific P/Q-type calcium channel blocker, ω-agatoxin-IvA, abolished oscillatory activity in the PPN, suggesting that oscillations were mediated by P/Q-type calcium channels. The increase in frequency of oscillations indicates that CAR changed the kinetic properties of the channels. Our data showed that M2 (G i -protein coupled) receptors can effectively block calcium channel-mediated oscillations acutely, but also increase the frequency of oscillations by activating intracellular mechanisms chronically. This dual effect of the M2 muscarinic receptor had never been reported in the PPN nucleus. we propose that persistent cholinergic activation of the PPN through the M2 receptors plays a key role in maintaining high-frequency activity among PPN neurons.
we then tested the participation of G-proteins in these effects. we found that no oscillations were observed in the presence of the G-protein blocker GDP-β-S, suggesting that availability of G-proteins is key to generating high-frequency oscillations in the PPN (Fig. 3a, b) . However, the G-protein stimulator GTP-γ-S did not change the ramp-induced oscillations (Fig. 3c, d ). The fact that the inactivation of G-proteins with GDP-β-S blocked oscillations, but stimulation of G-proteins with GTP-γ-S had no effect, suggesting that G-protein binding can plateau, beyond which no blockade of oscillations is possible . Furthermore, using a three-pulse protocol extensively by other authors (Ikeda 1996; Herlitze et al. 1996; Kammermeier et al. 2000) , one can test the effects of specific currents while G-proteins are bound (prepulse) and compare them, after delivering a depolarizing step that removes G-protein binding, to the response during a postpulse (Fig. 4a) . we found that CAR reduced calcium current amplitude of the prepulse more than the postpulse, suggesting a voltage-dependent G-protein mechanism (Fig. 4b, d ). In addition, acute CAR slowed the kinetics and reduced current amplitude of the calcium currents. The stimulatory effect of persistent CAR on calcium currents was prevented by adding GDP-β-S, and modulated similar effects on calcium currents only mediated by P/Q-type calcium channels (Fig. 4c, e) . This novel result explains why the persistent CAR effect did not induce a total blockade of oscillations. Partial blockade of P/Qtype channels and slower activation/deactivation kinetics than in control conditions would provide a mechanism for inducing faster frequencies of oscillations in the presence of CAR. G-protein modulation of potassium channels might also provide the faster membrane potential repolarization necessary to sustain higher frequencies of oscillations ).
The differences between the manifestations of oscillations in PPN cells during acute versus persistent exposure to CAR may be related to the presence of phasic versus tonic cholinergic input. That is, short duration cholinergic input to PPN neurons may tend to block the capacity to oscillate at high frequencies; however, under persistent, long duration, or tonic cholinergic influence, PPN neurons could oscillate at higher frequencies, especially in the gamma range. Phasic cholinergic tone may be more characteristic of patterns observed during REM sleep, in which PPN cells burst more, while persistent cholinergic tone is more characteristic of waking, when PPN cells tend to fire more tonically. we hypothesize that under phasic exposure to cholinergic input, G-proteins can still bind calcium channels, slowing their activation. This would reduce or prevent the induction of high-frequency oscillations through P/Q-type calcium channels. However, under tonic cholinergic input, G-proteins may be bound to the persistent input, maximizing their utilization, thereby freeing calcium channels to become activated at their membrane potential threshold, leading to sustained gamma frequency oscillatory activity. This "permissive inhibition" of G-proteins by tonic cholinergic input may be a mechanism for the maintenance of gamma band activity for prolonged periods . It would be of interest to determine whether this mechanism differs between gamma band activity during waking compared to that during REM sleep, and whether this mechanism is altered by total sleep or REM sleep deprivation.
Mechanisms for gamma activity during waking versus during REM sleep Increased arousal and increased REM sleep drive are perhaps the most common symptoms in a number of psychiatric and neurological disorders, yet the mechanism for their increase is not known and is not targeted for specific treatment. The recognition of the importance of these symptoms red) . However, the acute effect of CAR on oscillations was reversed by adding ATR to the solution (after 3 min of perfusion with a solution containing CAR + ATR) (right record, blue). This established that cholinergic muscarinic receptors were responsible for the effect. b Representative 1-s-long current ramp recording of a PPN neuron in the presence of SB + TTX + MEC + CAR (red record, top) recorded after persistent exposure to CAR (>20 min of exposure). Beside is the record of the same neuron showing that oscillations were blocked after adding ω-Aga (200 nM) to the extracellular solution (gray record, middle). These recordings confirm that P/Q-type calcium channel-mediated oscillatory activity in PPN neurons was induced by persistent activation by CAR. c Bar graph showing the mean frequency of oscillatory activity in the presence of SB + TTX, the nicotinic receptor blocker MEC, persistent exposure to CAR (red column), and in the presence of SB + TTX + CAR and nonspecific cholinergic antagonist ATR (blue column). Note that the mean oscillatory frequency of PPN neurons was significantly higher during persistent exposure to CAR compared to the condition with ATR in the extracellular solution. This suggests that CAR increased the frequency of oscillations in PPN cells dates back over 50 years! Classic studies determined that in schizophrenia, anxiety disorders, including posttraumatic stress disorder (PTSD), and bipolar and unipolar depression, increased vigilance and REM sleep drive (increased REM duration, decreased REM latency, hypervigilance, etc., usually coupled with decreases in slow wave sleep SwS) are major, incapacitating symptoms (Braff et al. 1978; Butler et al. 1990; Caldwell and Domino 1967; Coble et al. 1976; Feinberg et al. 1969; Jus et al. 1973; Krupfer 1976; Ross et al. 1989; Shalev et al. 1992; Zarcone et al. 1975 ). Most patients with schizophrenia, bipolar depression, male obsessive-compulsive disorder, and panic attacks develop the disorder postpubertally [~80 % between the ages of 15 and 25, during the normal decrease in REM sleep in humans (Roffwarg et al. 1966) ], while unipolar depression in adolescents is very high (Garcia-Rill 1997 (Garcia-Rill et al. 2003) . More recently, hypervigilance and REM sleep drive abnormalities have been confirmed in PTSD, nightmare disorder, ADHD, personality disorder, insomnia, depression, and Parkinson's disease (PD) (Hasler et al. 2013; Kirov et al. 2012; Manni et al. 2011; Pillai et al. 2011; Rieman et al. 2012; Schredl et al. 2012; Simor et al. 2013 ).
The differences between gamma band activity during waking versus REM sleep are unknown and hardly acknowledged. why is this important? Because it is high frequency, especially beta/gamma band activity that drives our cognitive function during waking but also our REM sleep, two obviously different states of awareness, and of memory consolidation. Our recent studies addressed the differential intracellular mechanisms assumed to subserve high-frequency activity during waking versus REM sleep as a prelude to the selective pharmacological modulation of these states. we know that the two states are differentially regulated in the PPN. Injections of glutamate into the PPN were shown to increase both waking and REM sleep, but injections of NMDA increased only waking, while injections of kainic acid (KA) increased only REM sleep (Datta 2002; Datta and Siwek 1997; Datta et al. 2001a, b) . Thus, the two states are independently activated by NMDA versus KA receptors. Moreover, the intracellular pathways mediating the two states appear to differ. For example, the CaMKII activation inhibitor, KN-93, microinjected into the PPN of freely moving rats resulted in decreased waking but not REM sleep (Data et al. 2010) . They also found that increased ERK1/2 signaling in the PPN is associated with the maintenance of sleep via suppression of waking (Desarnaud et al. 2011) and that the activation of intracellular protein kinase A (PKA) in the PPN instead contributed to REM sleep recovery following REM sleep deprivation (Datta and Desarnaud 2010) . These authors showed that during REM sleep, pCREB activation in PPN cholinergic neurons was induced by REM sleep, and that PPN intracellular PKA activation, and a transcriptional cascade involving pCREB occurred in cholinergic neurons (Datta et al. 2009 ). These results suggest that waking is modulated by the CaMKII pathway, while REM sleep is modulated by the cAMP-PKA pathway. In vivo recording studies have shown that PPN neurons manifest two major types of cellular activity in relation to waking and REM sleep in the form of "wake/REM on" and "REM on" cells (Datta and Siwek 2002) . This suggests that some PPN cells fire in relation to waking and REM sleep, and others only in relation to REM sleep, presumably through CaMKII and cAMP-PKA pathways versus only the cAMP-PKA pathway, respectively. Figure 5 shows results demonstrating that KN-93 blocked the ability of ramps to induce oscillations in PPN neurons (Fig. 5a ), an effect confirmed by the absence of oscillations in the power spectrum (Fig. 5b) . Recordings were carried out in the presence of synaptic blockers (SB), tetrodotoxin (TTX), and mecamylamine (MEC), a nicotinic receptor antagonist. These findings suggest that blocking the activation of CaMKII using KN-93 blocked the ability of ramps to induce gamma band oscillations in PPN neurons. These data suggest that CaMKII is necessary for the manifestation of ramp-induced oscillations in at least some PPN neurons. Fig. 4 Persistent voltage-independent G-protein modulation of voltage-gated calcium currents in PPN. a Three-pulse protocol was used to study the voltage dependence of G-protein modulation of calcium currents (ICa) in PPN neurons. b In the presence of synaptic receptor blockers (SB: gabazine-GBZ + strychnine-STR + NMDA blocker-AP5 + AMPA/KA blocker-CNQX), TTX and Mecamylamine-MEC (nicotinic receptor antagonist), calcium currents (ICa; black record) were reduced in amplitude when the three-pulse protocol was applied. Indeed, the ICa observed after the second 0 mv pulse (I2) was always of lower amplitude than the one observed after the first pulse (I1), yielding a I2/I1 < 1 in all neurons recorded. CAR (30 μM) reduced the total amount of current during both pulses without affecting calcium current amplitude I2/I1 ratios (red record). c The effects of CAR were prevented after adding GDP-β-S to the intracellular solution (1 mM). d The effect of CAR (red bar) was significantly reduced when either intracellular GDP-β-S (blank bar) or extracellular muscarinic receptor antagonists (M2 antagonist methoctramine-MTO + M1 antagonist pirenzepine-PIR) (hatched bar) were used. e Calcium current I2/I1 ratio values (%) were unchanged by CAR under any of the experimental conditions. These results suggest that CAR reduces calcium currents through the activation of muscarinic receptors that activate G-proteins
In collaboration with R. Llinas at NYU, we found that the effects of the stimulant modafinil (MOD) were also dependent on CaMKII, since its effects were blocked by the CaMKII activation blocker KN-93 ). Our previous studies using MOD (a) extensively characterized its effects on electrical coupling in the RAS and intralaminar thalamus, (b) established the concentration dependence of its effects in vitro and in vivo, (c) established the concentration dependence of its effects in animals and humans, and (d) determined that its effects were blocked specifically by gap junction blockers (Beck et al. 2008; Garcia-Rill et al. 2007 Heister et al. 2007; Kezunovic et al. 2010) . MOD, which typically takes 10-20 min to induce changes in electrical coupling, by itself does not appear to change gamma band oscillation frequency or amplitude. However, MOD was found to enhance CARinduced oscillation amplitude. we used synaptic blockers plus the nicotinic receptor antagonist MEC to tonically activate only muscarinic receptors using CAR. Figure 5c , d shows ramp-induced oscillations in the presence of SB + TTX + MEC before CAR application (C blue record, D blue line showing beta frequency oscillations at 25 Hz), but the addition of CAR for 20 min led to a significant increase in oscillation frequency (but not amplitude) to 50 Hz (C red record, D red line in power spectrum). Superfusion of MOD for 20 min in the presence of CAR significantly increased oscillation amplitude, but decreased oscillation frequency to 30 Hz (C black record, D black line in power spectrum). These results showed that MOD potentiated CAR-induced oscillation amplitude, but decreased their frequency from the gamma to the beta range in most cells, as was the case with MOD alone.
These data suggest that MOD preferentially promotes high-frequency activity through the CaMKII ("waking") pathway, especially in the presence of tonic cholinergic input. Moreover, work on cocaine abusers (Morgan et al. 2010) , and on an animal model of sleep-disordered breathing (Panckeri et al. 1996) , suggests that MOD may also decrease REM sleep. Further work will be needed to determine whether the cAMP/PK ("REM sleep") pathway is preferentially activated during REM sleep compared to the CaMKII pathway. These findings also provide intracellular targets for the modulation of memory consolidation during REM sleep and the effects of total versus REM sleep deprivation.
A mechanism for gamma modulation in schizophrenia Reduced gamma band activity has been reported in bipolar disorder (Ozerdem et al. 2011 ), but most attention has been devoted to this mechanism in schizophrenia. Aberrant gamma band activity and coherence during cognitive tasks or attentional load have been reported in schizophrenic patients (Uhlhaas and Singer 2010) . Several human studies demonstrated frequency-specific deficits in the coherence and maintenance of gamma oscillations in patients with schizophrenia (Spencer et al. 2003) . Schizophrenia is characterized by RAS symptoms such as hyperarousal, increased REM sleep drive, decreased SwS, and hallucinations, among others. The hallucinations in schizophrenia were proposed to represent overactive REM sleep intrusion into waking (Dement 1967; Mamelak and Hobson 1989) . That is, the states of waking and REM sleep, which are marked by gamma band activity, are both disturbed in schizophrenia. we found anatomical abnormalities specifically in RAS cholinergic neurons of the PPN in the brains of intractable inpatient (but not outpatient) schizophrenics (Garcia-Rill et al. 1995) , which accounts for some of the profound hyperarousal and sleep-wake dysregulation in the disease. In addition, increased neuronal calcium sensor protein-1 (NCS-1) expression is present in schizophrenia and bipolar disorder (Bergson et al. 2003; Koh et al. 2003) . That is, gamma band activity is reduced in precisely the same disorders that show NCS-1 over expression.
We hypothesize that over expression of NCS-1 and its regulation of intracellular calcium [Ca 2+ ] dynamics and modulation of P/Q-type channels underlie disorders that manifest decreased gamma band activity. Decreases in gamma band coherence and maintenance can account for many of the symptoms of schizophrenia. The positive symptoms include hallucinations, delusions, thought disorder, and agitation, while negative symptoms include lack of affect, anhedonia, and withdrawal. Cognitive symptoms include poor executive function, lack of attention, and disturbed working memory. All of these functions are associated with gamma band activity. However, despite known disturbances in gamma band coherence and maintenance in schizophrenia, none of the clinical trials completed or ongoing that tested modafinil (MOD) as a potential adjunct therapy assessed gamma band activity [Clinicaltrials.gov] . These trials assessed average safety (no safety issues, did not worsen positive symptoms) and average changes in cognitive function (not significant) or reduction in negative symptoms (reduced or unchanged) using neuropsychological testing, but none measured gamma band activity (Kane et al. 2010 (Kane et al. , 2012 . However, the postmortem results described above by Koh et al. (2003) suggest that only some patients with schizophrenia may suffer from significant over expression of NCS-1, which may be manifested as decreased gamma band activity only in a subpopulation of patients. No human study has measured gamma band activity and correlated it with NCS-1 levels. Unfortunately, serum sampling does not reflect brain levels, and, in fact, NCS-1 levels in leukocytes are actually decreased in schizophrenic patients (Torres et al. 2009 ). However, selecting patients on the basis of significantly reduced gamma band activity should provide a better test of our hypothesis. Before such testing can meet approval, we need specific information about the mechanisms at play in NCS-1 overexpression and MOD on the manifestation of gamma band activity. we need to answer the questions: does NCS-1 modulate gamma band oscillations, and at what concentrations? How much of it begins to decrease intrinsic gamma oscillations? Such studies can only be performed in vitro.
Interaction of calcium with a large number of calciumbinding proteins represents one of the mechanisms by which this second messenger controls many biological processes. NCS-1 is neuron specific (Martone et al. 1999 ) and has an affinity for calcium of 300 nM, i.e., within physiological levels (Cox et al. 1994) . NCS-1 regulates P/Q-type calcium channels (Tsujimoto et al. 2002) , neurotransmitter regulation (Pan et al. 2002) , intracellular protein trafficking (Taverna et al. 2002) , and G-protein-coupled receptor phosphorylation in a calcium-dependent manner, partly through CaMKII, at least in the heart (Nakamura et al. 2011) . NCS-1 also regulates the G-protein-coupled receptor kinase 1 (GRK1) gene that encodes G-proteins involved in modulating gamma band oscillations (Sallese et al. 2000) . Importantly, NCS-1 regulates various types of calcium channels, including N-and P/Q-type, with differences across species and location (reviewed in weiss et al. 2010) . However, there was no information on the effects of NCS-1 on RAS neurons. we provided answers to the questions: do low levels of NCS-1 increase gamma band activity? Do high levels of NCS-1 decrease gamma band activity? Does NCS-1 elicit its effects through CaMKII? Does MOD compete with high levels of NCS-1 (as would be observed in over expression) to restore gamma band activity?
we carried out studies to determine the effects of including NCS-1 in the recording pipette in order to allow its diffusion intracellularly only in the recorded neuron. Recording of oscillations was as described above. Figure 6a , b shows that soon after patching (A black record), the ramp typically induced low-amplitude oscillations (B black line in power spectrum). As the NCS-1 (1 μM) diffused into the cell, the amplitude and frequency of the gamma band oscillations increased significantly with time. The red record in A shows that, after 20 min of exposure to NCS-1 at 1 μM, oscillations increased in amplitude and frequency (B red line in power spectrum) and were maintained at these levels and higher after 40 min (blue record in A and blue line in the power spectrum in B). we recorded PPN cells for up to 1 h without decrement in oscillation amplitude or frequency. These spectacular findings are the first to show that NCS-1 at 1 μM significantly amplifies gamma band oscillations in RAS neurons. These results suggest that this concentration of NCS-1 would appear to be in the range at which this protein can modulate gamma band oscillations. The question then becomes, if this concentration is increased, as would be expected in overexpression, what is the effect on oscillations? we selected a concentration that would be quite high (and quite expensive), ten times or 10 μM, in the recording pipette. Figure 6c, d shows that soon after patching with NCS-1 at 10 μM (C blue record), oscillations were already of higher amplitude and frequency than without NCS-1 (D blue line in power spectrum). After 15 min, the amplitude (but not frequency) of the oscillations increased further (C red record, D red line in power spectrum). However, by 30 min, the oscillations were eliminated (C gray record, D gray line in power spectrum).
These results showed that NCS-1 at high concentration (10 μM) at first increased, then blocked gamma band oscillations in PPN neurons as it diffused into the cell. These findings suggest that 10 μM NCS-1 is "abnormal," presumably eliminating the activation of high-threshold calcium channels. In the same cells, we then tested the effects of 300 μM MOD administration for 20 min. MOD was able to restore low-amplitude, lower-frequency oscillations, despite the presence of NCS-1 at 10 μM (C black record, D black line in power spectrum). These results suggest that MOD was able to compete successfully with very high concentrations of NCS-1. In some cells, we applied ω-agatoxin-IvA, a specific P/Q-type calcium channel Fig. 6 Effects of NCS-1 at 1 μM in the recording pipette on oscillations induced at −30 to −10 mv by a ramp (bottom record) applied to a PPN cell held at −50 mv. a Oscillations were of low amplitude and frequency at the start (before NCS-1 diffused into the cell) but increased and were maintained after 20 min (red record) and 40 min (blue record). b The power spectrum of the recordings in a showed that oscillations increased in amplitude and frequency for prolonged periods. Effects of NCS-1 at 10 μM in the recording pipette on rampinduced oscillations in a PPN cell. c Soon after patching oscillations were in the gamma range (blue record), and remained for 15 min (red record), but were eliminated after 30 min (gray record), and returned 20 min after adding MOD (black record). d Power spectrum showing that NCS-1 at 10 mM had an immediate effect on oscillation amplitude and frequency (blue line), which persisted for 15 min (red line), but was then blocked by 30 min of exposure to high levels of NCS-1 (gray line), an effect partially reversed by MOD (black line) blocker, 15 min after patching with NCS-1 (1 μM) in the pipette and the oscillations were blocked, suggesting that P/Q-type channels are involved in the effects of NCS-1.
These studies represent a logical progression of controlled research to identify one of the causal factors behind decreased gamma band activity that affects at least some schizophrenic patients. They are designed to identify the intracellular mechanisms responsible for the manifestation of overexpression of NCS-1, the mechanisms behind a therapeutic agent that will compete for NCS-1 overexpression-induced decreases in gamma band activity, and verify the dynamic effects of these treatments on cells that control waking and REM sleep. The information generated using MOD, a drug already approved for human use, is promising in the design of clinical trials for a novel treatment for schizophrenia, strongly suggesting that this novel therapy may be effective specifically in those patients known to suffer from reduced gamma band activity, and, by assumption, perhaps not in those not suffering from this symptom. Such information will be critical to the success of a clinical trial. we also need information on the effects of sleep and REM sleep deprivation on NCS-1 and its modulation of gamma activity. while serotonin reuptake inhibitors may reduce REM sleep in depression and REM sleep deprivation appears beneficial in depressives, schizophrenics do not appear to respond with REM sleep rebound to deprivation (Berger and Riemann 1993; vogel 1975; Zarcone et al. 1975) . These results need to be confirmed with more modern methods, but the differential responses of these two mood disorders point to a potentially informative research avenue.
Conclusions
The discovery of gamma band activity in the RAS, in which virtually all cells are geared to fire at gamma frequencies, suggests that sensory afferent information triggers such activity in the mesopontine region. Through both ascending projections to the intralaminar thalamus and descending projections to the SubCD, high-frequency oscillations are relayed onto targets such as the cortex and hippocampus. These characteristics easily account for the proposal that the RAS is the critical agent in preconscious awareness. The RAS also possesses the necessary mechanism to maintain gamma band activity for prolonged periods. The fact that G-proteins must be occupied by cholinergic input in order to allow high-threshold calcium channels to oscillate, a permissive inhibition, suggests that the maintenance of gamma band activity is hard work. The behavioral and cellular data indicate that separate intracellular pathways mediate high-frequency activity during waking differentially from during REM sleep. These results point to potential novel targets for pharmacologically modulating each state differentially. One example of this approach is in the treatment for schizophrenia. Ten years ago, the overexpression of NCS-1 in schizophrenia was described, followed by studies showing a dysregulation in gamma band activity in the disease. Recent results account for both of these findings. They help describe how NCS-1 at low concentrations promotes high-threshold calcium channel-mediated gamma oscillations, which are reduced and blocked by high concentrations of NCS-1. Moreover, oscillations are restored by modafinil, suggesting a novel adjunct treatment, especially for negative symptoms in schizophrenia. Additional novel avenues for research make the RAS an exciting place to study, even after all these years.
